Navigation Links
DNA Medicine Institute Awarded NIH Grant for Emergency Point-of-Care Blood Sensor

CAMBRIDGE, Mass., March 9 /PRNewswire/ -- The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).  The grant is designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device.  The emergency blood sensor is designed to make these tests readily available under any scenario and easily performed by minimally trained personnel.  Applicable settings include hospitals, emergency rooms, physicians' offices, ambulances, global health clinics, and remote field locations.  The Institute envisions this technology will be integrated into its Universal Blood Sensor platform, which is designed to perform all hospital tests on a handheld, point-of-care device.

"We are pleased that the NIH is supporting our efforts to develop a potentially transformative human diagnostics platform.  The NHLBI understands the human impact of a point-of-care blood sensor that can diagnose acute blood loss, sepsis, and other critical health conditions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to further innovations in the point-of-care diagnostics field and speed development of a technology that can be utilized to make a difference for those in need."

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:

SOURCE DNA Medicine Institute

Back to top



SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chronically Ill Patients Find Help Paying For Medicines
2. Missouri Becomes the Fourth State to Connect to Kentuckys Real-time Cold Medicine Tracking System
3. Partnership for a Drug-Free Americas 21st Annual Teen Survey Shows No Significant Increase in Over-the-Counter Medicine Abuse Rates
4. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
5. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
6. GSK Statement on FDAs Proposed Label Revisions for Some Asthma Medicines
7. Americas Biopharmaceutical Companies Studying 183 New Medicines to Counter Diabetes Growth
8. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
9. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
10. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
11. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)...  ARKRAY USA , Inc., a ... demonstrating the accuracy of its blood glucose meter systems. ... Diabetes and Cardiovascular Disease in Los Angeles ... ® 01 meter and the Assure ® ... to accurately measure glucose levels in blood is essential ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 28, 2015 , ... There is only ... outperform our billings from last year? , This question has not been an easy ... coming to the retirement age and the younger workforce don’t share the same discipline ...
(Date:11/27/2015)... ... 2015 , ... According to an article published November 15th by ... handling security in light of the recent terrorist attacks in Paris, other cities are ... an attack from reaching U.S. soil. Especially around special events that may be high-profile ...
(Date:11/27/2015)... ... 27, 2015 , ... An inventor, from Hopkinsville, Ky., thought ... at home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. ... doing so, it could help to prevent potential overdose situations. As a result, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of “Supporting ... Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 ... through a vast social media strategy and across a network of top news ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the Radiology ... Building Better Radiology Marketing Programs meeting will showcase some of the best ... at Caesars Palace in Las Vegas with a pre-conference session on a collaborative ...
Breaking Medicine News(10 mins):